Contact: Mika Ono
Scripps Research Institute
Caption: Scripps Research Institute professor emeritus Charles Cochrane, M.D., led work that laid the foundation for the new drug Surfaxin, now approved in the United States for the treatment of infant respiratory distress syndrome.
Credit: Courtesy of The Scripps Research Institute.
Usage Restrictions: None
Related news release: Scripps Research discoveries lead to newly approved drug for infant respiratory distress syndrome